Crossmark

Acute hypervolemic hemodilution combined with controlled hypotension to minimize blood loss during operations of spine fusion: remifentanil versus magnesium sulfate

Crossref DOI link: https://doi.org/10.1186/s42077-021-00165-3

Published Online: 2021-08-28

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Elnaghy, Khaled Mohammed https://orcid.org/0000-0002-0073-6160
Nasr, Ibrahimabd-Elsalam

Kamal, Eman Mohamed
Funding

Funding for this research was provided by:

there are currently no funders
License Information

Text and Data Mining valid from 2021-08-28

Version of Record valid from 2021-08-28
More Information

Article History

Received: 6 June 2020

Accepted: 7 April 2021

First Online: 28 August 2021

Declarations

:

: This study was done after obtaining approval of Dr Sulaiman Alhabib hospital (Riyadh, Saudi Arabia) institutional review board (IRB) (Rn: ECAOO4/18) on 13/11/2018. Informed written consent was taken from all patients included.

: Informed written consent was taken from all patients included.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below